BioBoard
•  Ian Frazer Named Australian of the Year
•  Further Funding For Australian Medical Research
•  Blockbuster Gardisil Approved by FDA
•  Potential Ovarian Cancer Diagnostic Test on Trial in Melbourne
•  Seven Scientists Elected as CAS Foreign Members
•  CAS and University of Tokyo Set up Joint Laboratories
•  AstraZeneca to Invest $100 million in China
•  Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences (CAS) Partner with the Danish Pharmaceutical Company Lundbeck
•  Anti-flu Tamiflu Approved in China
•  China Develops New Bird Flu Vaccines
•  China Collaborates with WHO to Fight Infectious Diseases
•  Apollo Hospitals Eyes Acquisition in South-East Asia
•  India Opens New Free AIDS Therapy Centers
•  Ranbaxy Faces Criminal Charges for Price-fixing of Antibiotics and Warfarin
•  Nobel Laureate Norman E. Borlaug Calls for Gene Revolution in India
•  Carlyle Asia Growth Partners III Raises US$668 Million to Support Emerging Asian Business Leaders with Expansion Capital
•  Kyoto University and Summit Pharmaceuticals International Corp Collaborate
•  Grain Crisis Looms in Japan
•  University Student Named New Zealand's Young Scientist of the Year
•  New Boost in New Zealand Biotech Industry
•  HP and A*STAR to Open $30 Million R&D Lab
•  A*STAR to Collaborate with Australian National University
•  Singapore's BAC Announces Biomedical Research Data to be Off-limits to Third Parties

Special Feature
•  An Integrated Proteomic/Genomic Platform for Early Diagnosis of Cancer
•  Cancer Detection Using Biophotonics
•  Lovaxin C: Paving the Way for Listeria-based Cancer Vaccines

Industry Watch
•  An Australian Company -- Solagran Limited
•  World's First Transdermal Insulin from Australia
•  Circadian Technologies Ltd Forms New Company, Vegenics
•  Yale Ovarian Cancer Detection Technology Licensed in China by SurExam
•  Simcere Pharmaceutical Group Sets Foot in Anticancer Field
•  Bio-Bridge Science Builds Vaccine Facility in China
•  Novavax Inc and Bharat Biotech International Partner on the Development of Pandemic Influenza Vaccine
•  Genesis Receives $5.5M Payment
•  OraQuick? HIV Test Receives Approvals from Singapore Ministry of Health
•  Singapore-based SciGen Collaborates with Ferring on Recombinant Human Insulin
•  Singular ID's Patent Portfolio Strengthens and Grows
•  Bridge Announces $22 Million Capital Raise

Research Findings
•  Genomics Research in Australia -- The Genomic Disorders Research Center

Agriculture
•  Problems with the Cartagena Protocol

Alternative Medicine
•  History of Traditional Chinese Mediciner

Commentaries & Analysis
•  Asian Clinical Trial Market Set to Grow

Conference Calendar